Amygdala Insula Retraining in the Management of Perimenopause Symptoms
Chronic Conditions Research Fund
160 participants
Jun 20, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this study is to evaluate a neuroplasticity-based mind-body intervention, Amygdala and Insula Retraining (AIR), compared to a wait-list control in individuals experiencing perimenopausal symptoms. Our research questions include: Does AIR reduce overall perimenopausal symptom burden compared to a wait-list control? Does AIR improve sleep disturbance, vasomotor symptom interference, fatigue, mood, anxiety, and quality of life in perimenopausal individuals? Are symptom changes associated with improvements in autonomic regulation and sleep parameters, as reflected by exploratory wearable measures including heart rate variability?
Eligibility
Inclusion Criteria4
- Experiencing perimenopausal symptoms
- Meets STRAW+10 criteria based on self-assessment
- Able to read and understand English
- Access to internet
Exclusion Criteria6
- Pregnancy
- Presence of a severe psychiatric condition requiring immediate clinical intervention
- Uncontrolled thyroid disease or prolactinoma
- Active cancer treatment
- Inability to provide informed consent
- Any medical or psychiatric condition that, in the judgment of the investigator or study team, would interfere with safe participation or study completion
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Mind-body brain retraining intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07427459